Tuncez, MahmutTuran, KayaAydin, Ozgur DoganTuncez, Hulya Cetin2024-05-192024-05-1920231749-799Xhttps://doi.org10.1186/s13018-023-03950-yhttps://hdl.handle.net/20.500.12713/5654BackgroundTrigger finger is a common disease with a lifetime prevalence of 2%. One of the frequently preferred non-surgical treatments is blinded injection around the A1 pulley. This study aims to compare the clinical results of ultrasound-guided and blinded corticosteroid injection in the trigger finger.MethodsIn this prospective clinical study, 66 patients who had persistent symptoms of a single trigger finger were included. Patients with similar baseline characteristics such as age, gender, triggering period, and comorbidities were randomized. 34 patients had ultrasound-guided (UG), and 32 had blinded injections (BG). QDASH, VAS, time to return to work, and complications were compared between the groups.ResultsThe mean age was 52,66 (29-73) years. There were 18 male and 48 female patients. In the UG, the triggering resolved faster, returning to work was earlier, and the medication period was shorter (p < 0.05). A total of 17 patients who had diabetes mellitus received re-injections, 11 of which were in BG and 6 in UG (p < 0.05). Although statistically significantly lower scores were obtained in UG at the 1st and 4th weeks in the QDASH and VAS scores (p < 0.05), at the 12th and 24 weeks, there was no significant difference (p > 0.05).ConclusionUsing ultrasound guidance for corticosteroid injections is more effective for treating trigger fingers than the blinded method, leading to better results and a faster return to work in the early stages of treatment.eninfo:eu-repo/semantics/openAccessTrigger FingerSteroid InjectionUltrasound Guided InjectionArticle18137365603WOS:0010167703000012-s2.0-85163376596N/A10.1186/s13018-023-03950-yQ1